Cyr61 downmodulation potentiates the anticancer effects of zoledronic acid in androgen-independent prostate cancer cells
International Journal of Cancer (2009) - Comment
pubmed: 19530242  doi: 10.1002/ijc.24648  issn: 1097-0215  issn: 0020-7136 

Monica Marra, Daniele Santini, Giuseppina Meo, Bruno Vincenzi, Silvia Zappavigna, Alfonso Baldi, Maciej Rosolowski, Giuseppe Tonini, Markus Loeffler, Ruth Lupu, Santolo Rosario Addeo, Alberto Abbruzzese, Alfredo Budillon, Michele Caraglia